Answers are grounded in this paper and cite their sources.
Tight glycaemic control is essential, and good adherence is associated with a lower risk of all-cause mortality and hospitalisation in people with T2D. A significant number of people with T2D do not take medication as prescribed and therefore have poor outcomes. The key factors for not achieving targets include therapeutic inertia and adherence. Reasons for poor adherence include perception of treatment, complexity of treatment and adverse effects. Poor adherence leads to inadequate glycaemic control, which increases the risk of diabetic complications and mortality. There is evidence to suggest that education and monitoring is important in medication adherence.
No takes yet. Share an insight, caveat, or question.
Khunti et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: